Aliasger K. Salem - In situ treatment with a TLR9 agonist virus-like particle to promote immune responses against oral epithelial dysplasia progression

May 3, 2025

See the full article: https://link.springer.com/article/10.1007/s00262-025-04023-1

NSF Logo This material is based upon work supported by the National Science Foundation under Award No.2242763

Share this story